What's new

Orphan designation: ixodes ricinus contact phase inhibitor Treatment of non-traumatic spontaneous intracerebral haemorrhage, 25/03/2025 Positive

Orphan designation: ixodes ricinus contact phase inhibitor Treatment of non-traumatic spontaneous intracerebral haemorrhage, 25/03/2025 Positive

Apr 4, 2025 - 12:21
 0
Orphan designation: ixodes ricinus contact phase inhibitor Treatment of non-traumatic spontaneous intracerebral haemorrhage, 25/03/2025 Positive
Orphan designation: ixodes ricinus contact phase inhibitor Treatment of non-traumatic spontaneous intracerebral haemorrhage, 25/03/2025 Positive
Read More

Tags:

Previous Article

Apollomics tags out of TYG oncology pact to cut costs, extend runway into 2026

Next Article

As tariffs reshape global trade, North Carolina's economic future hangs in the b...

Related Posts

List of withdrawn medicinal products in accordance with...

Mar 7, 2025  0

Infographic - Orphan Medicines in the EU

Feb 27, 2025  0

Product Management Service (PMS) – Frequently Asked Que...

Feb 14, 2025  0